Recent Finacing
Recent Raise
Remix Therapeutics is a clinical-stage biotech developing oral small-molecule drugs that reprogram RNA processing using its REMaster platform combining data analytics, high-throughput screening, structural biology, and chemistry.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
